Scarica l'app Stockscreener
5.42
23.18%
1.02
Pre-mercato:
6.21
0.79
+14.58%
Precedente Chiudi:
$4.40
Aprire:
$4.45
Volume 24 ore:
238.26K
Relative Volume:
1.05
Capitalizzazione di mercato:
$179.42M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-61.45
EPS:
-0.0882
Flusso di cassa netto:
-
1 W Prestazione:
-9.06%
1M Prestazione:
-44.30%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.21
$5.60
Intervallo di 1 settimana:
$4.11
$6.04
Portata 52W:
$4.11
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Nome
Jupiter Neurosciences Inc
Settore
Industria
Telefono
(561) 406-6154
Indirizzo
1001 NORTH US HWY 1, JUPITER
Confronta JUNS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
5.42 | 179.42M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Jupiter Neurosciences Inc Borsa (JUNS) Ultime notizie
Jupiter Neurosciences refocuses on NLRP3 inflammasome By Investing.com - Investing.com South Africa
Jupiter Neurosciences refocuses on NLRP3 inflammasome - Investing.com India
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials - GlobeNewswire
Jupiter Neurosciences announces focus on NLRP3 pathway in JOTROL trials - TipRanks
Jupiter Neurosciences Targets NLRP3 Inflammasome With JOTROL Platform for Alzheimer's Treatment - StockTitan
Jupiter Neurosciences Inc. (JUNS) reports earnings - Quartz
Jupiter Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Jupiter Neurosciences inks deal for Southeast Asia expansion By Investing.com - Investing.com Australia
Jupiter Neurosciences inks deal for Southeast Asia expansion - Investing.com
Jupiter Neurosciences adjusts CFO compensation - Investing.com
Greenridge sees upside in Jupiter Neurosciences stock By Investing.com - Investing.com Canada
Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Citeline News & Insights
Tesla, Nvidia among Tuesday's market cap stock movers - Investing.com
Tesla, Nvidia among Tuesday's market cap stock movers By Investing.com - Investing.com UK
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Marvell, Credo Tech lead Friday's market cap stock movers By Investing.com - Investing.com South Africa
Marvell, Credo Tech lead Friday's market cap stock movers - Investing.com India
Adobe, Ciena lead Thursday's market cap stock movers By Investing.com - Investing.com South Africa
Adobe, Ciena lead Thursday's market cap stock movers - Investing.com
Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On ThursdayAkso Health (NASDAQ:AHG), Bloom Energy (NYSE:BE) - Benzinga
Opening Day: Jinxin Technology, zSpace make public debut - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
IPO NewsUS IPO Weekly Recap: ServiceTitan launches as small issuers slip through the IPO window - Renaissance Capital
Rx Rundown: Eli Lilly, Amgen, GSK and more - MM+M Online
Company behind novel Parkinson's disease treatment raises $11 million in IPO - The Business Journals
Jupiter IPOs to advance resveratrol-based treatments for neuroinflammation - Longevity.Technology
Grupo Aeroportuario del Pacifico Reports in November 2024 a Passenger Traffic Increase of 1.8% Compared to 2023 - The Manila Times
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering - GlobeNewswire
Jupiter Neurosciences Launches $11M IPO to Advance Parkinson's Disease Treatment Pipeline - StockTitan
Sumitomo Chemical Transfers Subsidiary Shares to GE HealthCare - MSN
IPO Roundup: Fast Track Group, MasterBeef and more - MSN
G50 Corp to Present at Sydney Investor Conference - MSN
Gildan Activewear, Inc. (GIL) Hit a 52 Week High, Can the Run Continue? - MSN
Aclaris Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - MSN
Tri Chemical Laboratories Reports Strong Financial Gains - MSN
Broadridge Stock Rises 11% in a Month: What You Should Know - MSN
Arteris, Inc. (AIP) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Dragon Rise Group Reports Revenue Surge, Holds Dividends - MSN
Apollo’s Novolex Explores Offer for Pactiv Evergreen - MSN
Jupiter Neurosciences stock rallies 37% following $11M IPO - MSN
2024's 10 Best-Performing Stocks - MSN
Why Accenture Stock Slumped Today - MSN
Agenus (AGEN) Stock Drops 5.50% Amid Biotech Sector Decline - GuruFocus.com
Morgan Stanley Upgrades Axon Enterprise (AXON) - MSN
Porch Stock Rockets After Firm Announces Upbeat Financial Targets Ahead Of Investor Day: Retail Sentiment Soars - MSN
Fastly price target raised to $10 from $8 at Piper Sandler - MSN
JUNS IPO NewsNeuro-inflammation biotech Jupiter Neurosciences prices IPO at $4, the low end of the range - Renaissance Capital
Don't Miss the Buying Opportunity in This Dividend King, Says Analyst - MSN
JUNSJUNS Latest Stock News & Market Updates - StockTitan
Jupiter Neurosciences Inc Azioni (JUNS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):